cs-1103
Small moleculeexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Feb 7, 2024 (NCT06316973)
Timeline
Indications
Mechanism of action
- fentanylANTAGONIST
fentanyl antagonist
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06721494 | Phase 2 | Mar 31, 2025 | Clear Scientific, Inc., National Institute on Drug Abuse (NIDA) |
| NCT06316973 | Phase 1 | Feb 7, 2024 | Clear Scientific, Inc., National Institute on Drug Abuse (NIDA) |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Clear Scientific, Inc. | For profit | 2 | 2 | 2 | 2024 |
| National Institute on Drug Abuse (NIDA) | Government | 2 | 0 | 2 | 2024 |
2 organizations
Page 1 / 1